Cambrian Biopharma: Cambrian Bio launches Amplifier Therapeutics to develop clinical-stage AMPK activator

The New York based biotech company announces launch of Amplifier Therapeutics to develop the clinical stage pan-AMPK activator, ATX-304 NEW YORK, March 14, 2023 /PRNewswire/ -- Cambrian

Related Keywords

New York ,United States ,Sweden ,Swedish ,Dennis Riedl ,Thomas Edlund ,James Peyer ,Helena Edlund ,Ruth Thieroff Ekerdt ,James Hall ,Olof Karlsson ,Rosa Argyropoulos ,Head Of Cardiovascular Business Development At Astrazeneca ,A Distributed Development Company ,Linkedin ,Global Corporate Communications ,Clinical Development ,Amplifier Therapeutics ,Cardiovascular Business Development ,Mechanism Phase ,Distributed Development Company ,Global Corporate ,Cambrian ,Iopharma ,Aunches ,Amplifier ,Herapeutics ,Evelop ,Linical ,Stage ,Campk ,Activator ,